Table 2. New Azole Antifungal Agents
| Agent | Status | Manufacturer |
|---|---|---|
| Voriconazole (Vfend®) | FDA-approved | Pfizer |
| Posaconazole (SCH56592; Noxafil) | Phase III trials | Schering Plough |
| Ravuconazole (BMS207147) | Phase II trials | Bristol Myers Squibb |
| Agent | Status | Manufacturer |
|---|---|---|
| Voriconazole (Vfend®) | FDA-approved | Pfizer |
| Posaconazole (SCH56592; Noxafil) | Phase III trials | Schering Plough |
| Ravuconazole (BMS207147) | Phase II trials | Bristol Myers Squibb |